Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model. [electronic resource]
Producer: 20191127Description: 313-323 p. digitalISSN:- 1791-244X
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.